1. Home
  2. PLBY vs RANI Comparison

PLBY vs RANI Comparison

Compare PLBY & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLBY

PLBY Group Inc.

SELL

Current Price

$1.03

Market Cap

123.4M

ML Signal

SELL

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

BUY

Current Price

$0.78

Market Cap

106.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
PLBY
RANI
Founded
1953
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
123.4M
106.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
PLBY
RANI
Price
$1.03
$0.78
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$2.83
★ $7.20
AVG Volume (30 Days)
★ 509.3K
489.6K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 87.50
57.14
EPS
★ N/A
N/A
Revenue
★ $120,928,000.00
$1,633,000.00
Revenue This Year
$6.60
$283.19
Revenue Next Year
$5.14
$5.99
P/E Ratio
★ N/A
N/A
Revenue Growth
4.13
★ 58.85
52 Week Low
$0.98
$0.45
52 Week High
$2.75
$3.87

Technical Indicators

Market Signals
Indicator
PLBY
RANI
Relative Strength Index (RSI) 36.99 44.31
Support Level N/A $0.73
Resistance Level $1.30 $0.84
Average True Range (ATR) 0.04 0.06
MACD -0.00 -0.00
Stochastic Oscillator 31.25 33.84

Price Performance

Historical Comparison
PLBY
RANI

About PLBY PLBY Group Inc.

Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: